The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2018 | Opioid use in sickle cell is not associated with in-hospital mortality in the US
Oladimeji Akinola Akinboro, MBBS, of Boston University School of Medicine and Boston Medical Center, Boston, MA, presents the finding from a national inpatient sample of sickle cell disease (SCD) in the US, which revealed that opioid use in SCD patients is not associated with in-hospital mortality. This indicates that use for pain management appears safe and should not be witheld when indicated.
